Company · CIK 0001509261 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Rezolute, Inc. · RZLT
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 FForm 4 → | Sep 3, 4:42 pm EDT | Sunil Ratilal KarnawatChief Commercial Officer | 2,267 | $4.50 | $10,202 | 69,275 | — | |
| Jul 2, 2026 FForm 4 → | Jul 7, 6:36 pm EDT | Brian Kenneth RobertsChief Medical Officer | 3,062 | $4.99 | $15,279 | 293,851 | — | |
| Jul 2, 2026 FForm 4 → | Jul 7, 5:27 pm EDT | Nevan C ElamCEO, Director | 8,004 | $4.99 | $39,940 | 605,497 | — | |
| Jul 2, 2026 FForm 4 → | Jul 7, 5:26 pm EDT | Daron EvansCFO | 3,062 | $4.99 | $15,279 | 411,400 | — |
Reported at this company — derivatives (options, RSUs, warrants)
No reported derivative activity in this period.